Aptima CMV Quant Assay, Reference numbers: AW-22600-001, AW-25509-001, and AW-26381-001 Amplifica...
FDA Device Recall #Z-1371-2024 — Class II — September 14, 2023
Recall Summary
| Recall Number | Z-1371-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 14, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Hologic, Inc. |
| Location | San Diego, CA |
| Product Type | Devices |
| Quantity | 684 kits |
Product Description
Aptima CMV Quant Assay, Reference numbers: AW-22600-001, AW-25509-001, and AW-26381-001 Amplification Reagent, Enzyme Reagent, Promoter Reagent, Amplification Reconstitution Solution, Enzyme Reconstitution Solution, Promoter Reconstruction solution, Target capture Reagent, Reconstitution Collars.
Reason for Recall
Use of assay along with plasma specimen may result in error code which would invalidate sample.
Distribution Pattern
Worldwide - US Nationwide distribution in the states of CA, CT, FL, ID, IL, MD, MI, MO, TN, TX, WI and the countries of Australia, Germany, Denmark, Spain, France, Great Britain, Italy, Norway, Qatar, Sweden.
Lot / Code Information
Lot #: 402941/ UDI:15420045514553
Other Recalls from Hologic, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1095-2025 | Class II | The Rapid fFN Specimen Collection Tube (PN: 715... | Jan 8, 2025 |
| Z-0907-2025 | Class II | Panther Fusion GBS Assay REF PRD-04484 Kit cont... | Dec 13, 2024 |
| Z-0694-2025 | Class II | Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, RE... | Nov 8, 2024 |
| Z-0782-2024 | Class II | PANTHER FUSION System REF 9121010000 The P... | Dec 15, 2023 |
| Z-1144-2023 | Class II | Hologic 3Dimensions/Selenia Dimensions Models... | Jan 16, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.